KRISTI LICKTEIG: Open Payments
NPI 1437770559 · GARNETT, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 22 payments from 7 companies in 2025. Trend: 2023 $860 · 2024 $670 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $126 |
| Otsuka America Pharmaceutical, Inc. | 5 | $92 |
| Lundbeck LLC | 3 | $55 |
| ABBVIE INC. | 2 | $40 |
| Alkermes, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: COBENFY, ABILIFY ASIMTUFII, REXULTI, VRAYLAR, CAPLYTA, ARISTADA, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
